NXGL NEXGEL, Inc. logo

NXGL NEXGEL, Inc.

Healthcare
$0.54+0.93%ClosedMarket Cap: $4.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

1.11

P/S

0.44

EV/EBITDA

-3.07

DCF Value

$-266.03

FCF Yield

-28.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

38.9%

Operating Margin

-31.4%

Net Margin

-28.5%

ROE

-70.2%

ROA

-27.7%

ROIC

-40.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$2.6M$-927.0K$
Q4 null$2.8M$-970.0K$
FY null$11.4M$-3.0M$
Q3 null$2.9M$-653.0K$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell
Maxim GroupBuy
2026-03-12

Trading Activity

Insider Trades

View All
Levy Adam R.director, officer: Chief Executive Officer
BuyMon May 18
Levy Adam R.director, officer: Chief Executive Officer
BuyMon May 18
Kieser Brian Josephdirector
BuyMon May 18
Kieser Brian Josephdirector
BuyMon May 18
Kieser Brian Josephdirector
SellMon May 18

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

0.74

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.

Peers